Aurobindo Pharma

Aurobindo to buy Sandoz’s dermatology business in US for $1 bn

07 Sep 2018

Aurobindo will pay $900 million for about 300 products, three manufacturing facilities in the US and Eon Labs Inc, a wholly owned unit of Sandoz Inc, besides performance-based payments of $100 million on products in the pipeline

Aurobindo acquires Apotex's business in 5 European countries for €74 mn

16 Jul 2018

Aurobindo and others in the race to buy Novartis portfolio of US assets

12 May 2018

If Aurobindo Pharma is successful in clinching the deal, it would be the largest acquisition of an overseas business by any Indian drug producer, after Lupin's 2015 acquisitions of Gavis Pharmaceuticals and Novel Laboratories for $880 million, in a cash-free and debt deal

Aurobindo in race to acquire generic dermatology business from Novartis

07 May 2018

Aurobindo Pharma acquires Portuguese firm for Rs970 crore

09 Jan 2017

Aurobindo Pharma to buy some commercial products from Teva

26 Nov 2016

Aurobindo, Intas in race for Teva's Irish generics business

29 Aug 2016

Aurobindo Pharma mulls bidding for Teva Pharmaceutical’s $1.5 bn drug portfolio

05 Jul 2016

Aurobindo Phrma to set up plant in S Arabia

11 Jan 2016

Aurobindo Pharma receives US FDA Approval for Norethindrone Acetate Tablets

11 Jan 2016

Aurobindo gets US FDA nod to market injectable form of Warner Chilcot’s Actonel tablets

03 Dec 2015

3 Indian firms get FDA nod to sell generic hypertension drug

07 Jan 2015

Aurobindo Pharma completes $132.5-m acquisition of US firm Natrol

06 Dec 2014

Aurobindo Pharma to buy US nutritional supplement maker Natrol for Rs 813 crore

12 Nov 2014

Aurobindo Pharma to acquire Actavis’s European operations

18 Jan 2014

Aurobindo Pharma will acquire the generics commercial operations of Actavis Plc in seven markets across Western Europe

Aurobindo Pharma rejigs execs in wake of ‘Jagan scam’

31 May 2012

Aurobindo Pharma in generic drugs JV with Russia's Diod

07 Sep 2011

Aurobindo receives USFDA approval for Alprazolam extended-release tablets

08 Jun 2011

Sinopharm to acquire 80-% stake in Aurobindo's China subsidiary

11 Jan 2011

Aurobindo Pharma receives USFDA approvals for Ampicillin for Injection

23 Aug 2010

Aurobindo Pharma epilepsy drug gets Canadian approval

22 Mar 2010

Aurobindo Pharma's antibiotic ANDA gets Canadian approval

03 Mar 2010

Aurobindo gets US FDA nod for 50mg dosage of HIV drug `Nevirapine'

26 Feb 2010

Aurbindo to merge subsidiary Trident Life Sciences Ltd

13 Nov 2009

Aurobindo Pharma receives USFDA, Swissmedic approval for drugs

07 Sep 2009

View details about the software product Informachine News Trackers